Deutsche Bank
CPXX

Deutsche Bank’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Deutsche Bank’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-996,192
Closed -$30.1M – 5518
2016
Q2 		$30.1M Buy
996,192
+980,338
+6,184% +$19.9M 0.02% 722
2016
Q1 		$174K Buy
+15,854
New +$52K ﹤0.01% 3726
2015
Q2 		– Sell
-44
Closed – – 5582
2015
Q1 		$0 Sell
44
-2,256
-98% -$6.07K ﹤0.01% 6356
2014
Q4 		$4K Buy
+2,300
New +$4.77K ﹤0.01% 5942

Deutsche Bank's CPXX Position: Q3 2016 in Review

Deutsche Bank sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 996,192 shares — an estimated $30.1M sold.

Deutsche Bank first reported a position in CPXX in Q4 2014 and held it in 4 quarters. The position peaked at $30.1M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Deutsche Bank reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Deutsche Bank sold 996,192 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $30.1M.
  • Deutsche Bank first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2014 and held it in 4 quarters.
  • Deutsche Bank's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $30.1M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.